Figure. Spoligotypes and drug-resistance patterns of isolates of patient's first (1 and 2, type I) and second culture-positive phase (3-8, type II). The spoligotypes of the first two cultures differ clearly from those of the latter ones. The eight isolates were obtained on the following dates: 1, February 28, 1996; 2, March 17, 1996; 3, June 6, 1996; 4, July 12, 1996; 5, March 15, 1997; 6, April 25, 1997; 7, February 18, 1998; and 8, June 23, 1998. H, isoniazid; S, streptomycin; R, rifampin; E, ethambutol; Rb, rifabutin; Pt, protionamide; Z, pyrazinamide; Pa, p=aminosalicylic acid; Am, amikacin. Borderline results are displayed in brackets.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.